NextCure Statistics

Total Valuation

NextCure has a market cap or net worth of $12.16 million. The enterprise value is -$49.51 million.

Market Cap	12.16M
Enterprise Value	-49.51M

Important Dates

The last earnings date was Thursday, May 1, 2025, after market close.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

NextCure has 28.01 million shares outstanding. The number of shares has increased by 0.44% in one year.

Current Share Class	28.01M
Shares Outstanding	28.01M
Shares Change (YoY)	+0.44%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	1.89%
Owned by Institutions (%)	33.34%
Float	21.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.19
P/TBV Ratio	0.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-37.49%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.68% in the last 52 weeks. The beta is 1.04, so NextCure's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-73.68%
50-Day Moving Average	0.50
200-Day Moving Average	1.02
Relative Strength Index (RSI)	48.98
Average Volume (20 Days)	214,711

Short Selling Information

The latest short interest is 182,944, so 0.65% of the outstanding shares have been sold short.

Short Interest	182,944
Short Previous Month	35,771
Short % of Shares Out	0.65%
Short % of Float	0.87%
Short Ratio (days to cover)	0.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.07M
Pretax Income	-61.28M
Net Income	-49.52M
EBITDA	-50.27M
EBIT	-53.07M
Earnings Per Share (EPS)	-$1.77

Full Income Statement

Balance Sheet

The company has $68.62 million in cash and $5.95 million in debt, giving a net cash position of $62.67 million or $2.24 per share.

Cash & Cash Equivalents	68.62M
Total Debt	5.95M
Net Cash	62.67M
Net Cash Per Share	$2.24
Equity (Book Value)	65.47M
Book Value Per Share	2.34
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	-41.63M
FCF Per Share	-$1.49

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NextCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.44%
Shareholder Yield	-0.44%
Earnings Yield	-376.38%
FCF Yield	-316.40%

Analyst Forecast

The average price target for NextCure is $3.50, which is 705.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.50
Price Target Difference	705.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.37%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a